• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Covidien’s Meelia rejoins Haemonetics board as chairman | Personnel Moves

Covidien’s Meelia rejoins Haemonetics board as chairman | Personnel Moves

June 6, 2011 By MassDevice staff

Haemonetics
Covidien

Richard Meelia, the outgoing CEO of Covidien plc (NYSE:COV), is re-joining the board of directors at Haemonetics Corp. (NYSE:HAE) two years after stepping down to focus on Covidien.

Meelia, who plans to retire from Covidien’s corner office July 1 (he’ll stay on as non-executive chairman for the Mansfield, Mass.-based medical products maker), served on Haemonetics’ board from 2005 through 2009.

The now-62-year-old Meelia resigned his seat, the company said at the time, “in order to spend more professional time on Covidien’s operations," which were smack in the middle of a major restructuring. He has a big-league pedigree from nearly 40 years in the health care trenches, including stints leading Covidien pre-cursors Tyco Healthcare and Kendal Healthcare Products.

"I look forward to rejoining the Haemonetics Board of Directors and serving the Company’s shareholders," Meelia said in prepared remarks. "Brian and his team have done a terrific job in growing the business and I believe Haemonetics is well-positioned to succeed going forward."

In March, Covidien announced that it named the head of its medical device arm, José Almeida, to replace Meelia. Almeida is the headliner at the MassDevice Big 100 Regional Roundtable slated for July 11.

Systagenix shuffles the deck at CEO
Systagenix Wound Management named Ernest Waaser as CEO, replacing Steve Atkinson, who’s led the firm since it was spun out of Johnson & Johnson’s (NYSE:JNJ) advanced wound care business in 2008.

Back in October 2009, Atkinson told MassDevice that the company planned to revitalize the product development pipeline that had gone slack at J&J. Late last year, Systagenix inked a deal with ECI Biotech to develop a point-of-care diagnostic for infections of chronic wounds.

Read more

Filed Under: News Well Tagged With: Covidien, Haemonetics, Personnel Moves, Systagenix Wound Management Inc.

More recent news

  • Neuralink files to raise $649M in new equity offering
  • BofA: Surgical robot remanufacturing not a major setback for Intuitive
  • InspireMD wins CE Mark approval for CGuard Prime
  • Philips reports first cases for VeriSight Pro 3D ICE catheter in Europe
  • Ceryx Medical raises $15M to support bioelectronic pacemaker

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy